Certified Pre-Owned
No Preference
tamoxifen retinopathy The IES study confirmed that switching to an aromatase inhibitor AI such as exemestane after 2 3 years of tamoxifen therapy resulted in improved survival relative to women remaining on 5 years of tamoxifen therapy
There are no questions yet for this shipment. Be the first to ask one!
There are no carriers bidding for this shipment yet. Be the first to bid!